Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Aiwu Ruth He"'
Autor:
Chao Yin, Samantha Armstrong, Richard Shin, Xue Geng, Hongkun Wang, Rohit S. Satoskar, Thomas Fishbein, Coleman Smith, Filip Banovac, Alexander Y. Kim, Aiwu Ruth He
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 2, Pp 295-305 (2023)
Abstract Background and Aims In patients with surgically unresectable early and intermediate stage hepatocellular carcinoma (HCC), only liver transplant (LT) offers a cure. Locoregional therapies, such as transarterial chemoembolization (TACE), are w
Externí odkaz:
https://doaj.org/article/742d816c09254df2b54b937ce9fc745a
Autor:
Shuyi Chen, Huijie Wu, Zhengyang Wang, Mengping Jia, Jieyu Guo, Jiayu Jin, Xiaobo Li, Dan Meng, Ling Lin, Aiwu Ruth He, Ping Zhou, Xiuling Zhi
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 3, Pp 949-973.e7 (2022)
Background & Aims: Loss of Spectrin beta, non-erythrocytic 1 (SPTBN1) plays an important role in the carcinogenesis of hepatocellular carcinoma (HCC); however, the mechanisms underlying its involvement remain poorly understood. Defects in autophagy c
Externí odkaz:
https://doaj.org/article/141eea37d6154be8810b537e17716301
Autor:
Neil J. Shah, Ghassan Al-Shbool, Matthew Blackburn, Michael Cook, Anas Belouali, Stephen V. Liu, Subha Madhavan, Aiwu Ruth He, Michael B. Atkins, Geoffrey T. Gibney, Chul Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-8 (2019)
Abstracts Background Patients with chronic viral infections including human immunodeficiency virus (HIV), hepatitis B (HBV) and hepatitis C (HCV) are at increased risk of developing malignancies. The safety and efficacy of ICI therapy in patients wit
Externí odkaz:
https://doaj.org/article/4743136d3aca4386b8f42d2ba43cf2b8
Autor:
Amaia Lujambio, Thomas Yau, Lipika Goyal, Andrew X Zhu, Ignacio Melero, Tim F Greten, Ann-Lii Cheng, Bruno Sangro, David J Pinato, Peter R Galle, Ghassan K Abou-Alfa, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Donna Mabry Hrones, Roberto I Troisi, Andrea Wilson Woods
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)
Patients with advanced hepatocellular carcinoma (HCC) have historically had few options and faced extremely poor prognoses if their disease progressed after standard-of-care tyrosine kinase inhibitors (TKIs). Recently, the standard of care for HCC ha
Externí odkaz:
https://doaj.org/article/c395a80c692945e793e9d243958829ae
Autor:
Christine C. Hsu, Sunil Bansal, Hong Cao, Coleman I. Smith, Aiwu Ruth He, Martha D. Gay, Yaoxiang Li, Amrita Cheema, Jill P. Smith
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 627 (2022)
Proglumide is an orally administered cholecystokinin receptor antagonist that was found to improve nonalcoholic steatohepatitis, reverse liver fibrosis, and decrease incidence of hepatocellular carcinoma (HCC) in animal models. The current investigat
Externí odkaz:
https://doaj.org/article/34f79e6a0fc648e294d586017c4f2aa0
Autor:
Andrew eGabrielson, Akemi eMiller, Filip eBanovac, Alexander eKim, Aiwu Ruth He, Keith eUnger
Publikováno v:
Frontiers in Oncology, Vol 5 (2015)
Purpose: We sought to report outcomes and toxicity in patients with hepatocellular carcinoma (HCC) who received resin Yttrium-90 Selective Internal Radiation Therapy (90Y-SIRT), and to identify factors associated with declining liver function.Methods
Externí odkaz:
https://doaj.org/article/8dde8db129e04e75b349cba91637c636
Autor:
Nitesh eRana, Andrew Wenhua Ju, Michael eBazylewicz, Bhaskar eKallakury, Aiwu Ruth He, Keith R Unger, Justin S Lee
Publikováno v:
Frontiers in Oncology, Vol 3 (2013)
Purpose: Ytrrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering tumor vascularity or suppressi
Externí odkaz:
https://doaj.org/article/f30cd351fe3342f1b288ec5ae43bb94a
Autor:
Sameh Mikhail, Aiwu Ruth He
Publikováno v:
International Journal of Hepatology, Vol 2011 (2011)
Hepatocellular carcinoma is the most common primary malignancy of the liver in adults. It is also the fifth most common solid cancer worldwide and the third leading cause of cancer-related death. Recent research supports that liver cancer is a diseas
Externí odkaz:
https://doaj.org/article/c105aae3a3b24f0fa14f47d766c8a611
Autor:
Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo, Ana Matilla, Aiwu Ruth He, Antonio Cubillo Gracian, Anthony B. El-Khoueiry, Bruno Sangro, Tarek E. Eldawy, Jordi Bruix, Giovanni Luca Frassineti, Gina M. Vaccaro, Marina Tschaika, Christian Scheffold, Petra Koopmans, Jaclyn Neely, Fabio Piscaglia
Publikováno v:
Journal of Clinical Oncology. 41:1747-1757
PURPOSE To investigate the safety and efficacy of nivolumab plus cabozantinib with or without ipilimumab in patients with advanced hepatocellular carcinoma. METHODS In cohort 6 of the multicohort, open-label, phase I/II CheckMate 040 study, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf11efcf4879d774f339045b67b1d7c5
https://doi.org/10.1200/jco.22.00972
https://doi.org/10.1200/jco.22.00972
Autor:
Chao Yin, Samantha Armstrong, Richard Shin, Xue Geng, Hongkun Wang, Rohit S. Satoskar, Thomas Fishbein, Coleman Smith, Filip Banovac, Alexander Y. Kim, Aiwu Ruth He
Publikováno v:
Annals of Gastroenterological Surgery. 7:295-305
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::834aacad460f6886231eb040db8fc547
https://doi.org/10.1002/ags3.12622
https://doi.org/10.1002/ags3.12622